二重弁置換手術を受けた患者のデング熱心筋炎の管理,VA ECMO症例報告
Vipul Bansal1, Vivek Gupta1, Naved Aslam1
1Hero DMC Heart Institute, Ludhiana, Punjab, India.
The International journal of artificial organs
|August 25, 2025
まとめ
このケーススタディは,デング熱ショック症候群,義肢弁,重度の心臓機能不全の重症肥満患者の静脈動脈外膜酸素化 (VA ECMO) の成功管理を強調しています. 複雑な症例の 集中治療における課題を 詳細に説明します
科学分野:
- 心臓病科
- 集中治療 医療
- 感染症
背景:
- デング熱ショック症候群は,心筋機能障害や悪性不律症を含む重度の心臓合併症を引き起こす可能性があります.
- 心臓弁の義肢を持つ患者は,特に重篤な全身疾患の際に,重症治療施設でユニークな課題を提示します.
- 病的な肥満は,生理学的変化と臓器機能障害のリスクの増加により,管理をさらに複雑にする.
研究 の 目的:
- VA ECMOを用いた重度の心臓機能不全と義足弁を伴うデング熱ショック症候群の複雑な症例の成功管理について説明する.
- 既にある併発性疾患と義肢装置の患者におけるVA ECMOの開始と管理における課題と考慮事項を強調する.
- VA ECMOと継続的な腎置換療法 (CRRT) が重症デング熱の際に多臓器機能障害を支援する役割について議論する.
主な方法:
- デング熱ショック症候群,心房不律症,多臓器機能障害を呈した45歳の肥満男性.
- エコーカルディオグラフィでは,左心室の重度の機能不全 (LVEF 8% - 10%),人工弁の合併症がないことが示されました.
- 炎症性心律不全,急性腎臓損傷,肝機能不全の管理のために,静脈ECMOとOxirisフィルター付きCRRTを開始しました.
主要な成果:
- 患者はVA ECMOのサポートで血動力学的安定化と回復を成功させた.
- Oxirisフィルターによる継続的な腎置換療法は,急性腎損傷と肝機能障害の管理に役立ちました.
- 義肢弁と既にある心筋機能不全によって 課題が生じたにもかかわらず,VA ECMOは 循環器と呼吸器の 重要なサポートを提供しました.
結論:
- VA ECMOは,重度の心臓機能不全と多臓器不全に合併したデング熱ショック症候群の患者において, 義肢弁を備えた場合でも, 命を救う介入となります.
- ECMO治療中に義肢弁と既にある疾患に関連した課題を克服するには,慎重に患者の選択と管理が不可欠です.
- このケースは 複雑な併発性疾患を扱う上で 最先端の 機械的循環支援の重要性を強調しています
関連する概念動画
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30


